Craig B. Thompson Charles River Laboratories International, Inc. (CRL) insider trading activity

CRL Quotes by TradingView

Craig B. Thompson is Director of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 2,413 shares of CRL, which is worth approximately $364,363. The most recent transaction as insider was on May 21, 2025, when has been sold 946 shares (Common Stock) at a price of $134.98 per share, resulting in proceeds of $127,691. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.41K
64.49% 3M change
64.49% 12M change
Total Value Held $364,363

Craig B. Thompson Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2025
BUY
Grant, award, or other acquisition
$127,691 $134.98 p/Share
946 Added 28.16%
2,413 Common Stock
May 13 2024
BUY
Grant, award, or other acquisition
$127,681 $228.41 p/Share
559 Added 27.59%
1,467 Common Stock
May 15 2023
BUY
Grant, award, or other acquisition
-
664 Added 42.24%
908 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
244 Added 50.0%
244 Common Stock

Also insider at

MRK
Merck & Co., Inc. Healthcare
Director
REGN
REGENERON PHARMACEUTICALS, INC. Healthcare
Director
CBT

Craig B. Thompson

Director
Kenilworth, NJ

Track Institutional and Insider Activities on CRL

Follow CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRL